Technology transfer mandates include a role as Quality Site Head at a manufacturing facility in Germany (DRK Blutspendedienst) which was contracted by Kiadis Pharma, an Amsterdam-based cell therapy company. This role included transfer of development processes from the originator site in the Netherlands to a commercial production site in Germany, as well as management of quality engineering processes until PPQ runs. Additionally, the role included collaboration with external engineering companies to manage the project from planning to commissioning. Another important part of the mandate was the oversight of aseptic work practices, cleanroom techniques, and GMP inspection readiness. Other mandates in technology transfer include a role at Johnson & Johnson aimed at transferring the small-scale in-house COVID-19 vaccine production to an external CMO. This role emphasized planning and execution of a seamless collaboration between CMC- and supply chain teams, while facing the challenges of a high-pressure environment during the pandemic.